Showing results (31-40 of 491) with videos related to
Sort By:
Pageof 50
Biosensors & Bioelectronics|October 27, 2001
Disposable TSM-biosensor based on viscosity changes of the contacting mediumS P Sakti, R Lucklum, P Hauptmann, et al.The American Journal of Pathology|March 10, 2001
A putative role for cathepsin K in degradation of AA and AL amyloidosisC Röcken, B Stix, D Brömme, et al.FEBS Letters|July 21, 1997
The activation-dependent induction of APN-(CD13) in T-cells is controlled at different levels of gene expressionT Wex, F Bühling, M Arndt, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 23, 1999
Increased release of transforming growth factor (TGF)-beta1, TGF-beta2, and chemoattractant mediators in pneumoniaF Bühling, G Thölert, D Kaiser, et al.Journal of Immunological Methods|February 14, 1998
A detailed protocol for the measurement of TGF-beta1 in human blood samplesD Reinhold, U Bank, F Bühling, et al.The Journal of Biological Chemistry|December 31, 1997
The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growthS Wrenger, T Hoffmann, J Faust, et al.Advances in Experimental Medicine and Biology|January 1, 1997
CD26/dipeptidyl peptidase IV in lymphocyte growth regulationS Ansorge, F Bühling, T Kähne, et al.Advances in Experimental Medicine and Biology|June 13, 2000
Dipeptidyl peptidase IV in inflammatory CNS diseaseA Steinbrecher, D Reinhold, L Quigley, et al.Advances in Experimental Medicine and Biology|June 13, 2000
Dipeptidyl peptidase IV (CD26): role in T cell activation and autoimmune diseaseD Reinhold, B Hemmer, B Gran, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivoA Steinbrecher, D Reinhold, L Quigley, et al.Pageof 50